| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/01/2006 | CN1239713C Application of ion channel inhibitor for curing arhythmia |
| 02/01/2006 | CN1239491C Method for extracting total phenyl phthalein of ligusitcum wallichii |
| 02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 02/01/2006 | CN1239197C Oral preparation for cerebral embolism and its preparing method |
| 02/01/2006 | CN1239195C Compound flavone capsule and pellet prepn. method |
| 02/01/2006 | CN1239194C Chinese patent medicine for treating coronary heart disease and angina pectoris |
| 02/01/2006 | CN1239190C Chinese traditional medicine particle for treating pulmonary heart disease |
| 02/01/2006 | CN1239182C Chinese traditional medicine composition for treating cerebral infarction and hyperlipoidemia |
| 02/01/2006 | CN1239181C Chinese patent medicine for treating apoplexy |
| 02/01/2006 | CN1239180C Medicine for treating piles |
| 02/01/2006 | CN1239177C Chinese herbal medicine for treating piles |
| 02/01/2006 | CN1239164C Haw effective part and its extracting method and uses |
| 02/01/2006 | CN1239163C Medicine composition for treating cerebrovascular disease |
| 02/01/2006 | CN1239160C Hormone replacement therapy |
| 02/01/2006 | CN1239155C Medicinal composition for treating ischemic cerebrovascular accident and preparation method |
| 02/01/2006 | CN1239151C Tablets quickly disintegrating in oral cavity |
| 01/31/2006 | US6992215 Thiol-based NAALADase inhibitors |
| 01/31/2006 | US6992194 suspending crystal strutured or amorphous lipitor in diluents comprising alcohols and/or water mixtures to cause conversion, then separating the diluents; monodispersity |
| 01/31/2006 | US6992192 preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase used for prophylaxis of erectile dysfunction and cardiovascular disorders |
| 01/31/2006 | US6992171 Polypeptide and its DNA |
| 01/31/2006 | US6992105 N-[2-[(S)-2-Acetylthio-3-methylbutanoylamino]-2-methylpropionyl]-O-ben-zyl-L-serine Ethyl; inhibitors of angiotensin converting enzyme, neutral endopeptidase, endothelin converting enzyme. |
| 01/31/2006 | US6992103 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease |
| 01/31/2006 | US6992094 selenium nicotinic acid tetrahyronaphthaline compounds; treating skin disorders |
| 01/31/2006 | US6992086 Antagonists of MCP-1 function and methods of use thereof |
| 01/31/2006 | US6992074 2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 01/31/2006 | US6992067 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 01/31/2006 | US6992066 Povidone-containing carriers for polypeptide growth factors |
| 01/31/2006 | US6992064 Central nervous system disorders; antidepressants |
| 01/31/2006 | US6991936 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 01/31/2006 | US6991901 Administering an antibody to the polypeptide sec1; angiogenesis inhibitors |
| 01/31/2006 | US6991816 Aqueous solution of flavonoids and anthocyanins |
| 01/31/2006 | US6991812 Agent for preventing, improving or treating hypertension |
| 01/31/2006 | US6991804 Delivery systems for periadventitial delivery for treatment of restenosis and anastomotic intimal hyperplasia |
| 01/31/2006 | CA2433193C Amide derivative of amlodipine |
| 01/31/2006 | CA2327498C Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 01/31/2006 | CA2314154C Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 01/26/2006 | WO2006009464A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 01/26/2006 | WO2006009092A1 Method of effectively using medicine and method concerning prevention of side effect |
| 01/26/2006 | WO2006009054A1 Phenethylnicotinamide compound |
| 01/26/2006 | WO2006008316A2 Selective inhibitors of human corticosteroid syntheses |
| 01/26/2006 | WO2006008091A2 Oxidative degradation products of atorvastatin calcium |
| 01/26/2006 | WO2005073236A3 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors |
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060020046 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
| 01/26/2006 | US20060020024 TNP-470 species, polymer conjugates and use thereof |
| 01/26/2006 | US20060020020 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 01/26/2006 | US20060020008 Compounds, compositions and methods |
| 01/26/2006 | US20060020002 (3a alpha ,4 alpha ,7 alpha ,7a alpha )-Octahydro-3-hydroxy-2-[4-nitro-3-(trifluoromethyl)phenyl]-4,7-methano-1H-isoindol-1-one (2); steroid mimic; competitive inhibitors of intercellular ligand binding reactions involving CAMs and Leukointegrins; anticarcinogenic agent; autoimmune diseases |
| 01/26/2006 | US20060019999 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 01/26/2006 | US20060019988 Compounds, compositions, and methods |
| 01/26/2006 | US20060019984 Treatment of diseases with alpha-7nACh receptor full agonists |
| 01/26/2006 | US20060019983 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 01/26/2006 | US20060019982 For therapy of central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 01/26/2006 | US20060019977 Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient |
| 01/26/2006 | US20060019974 4-Amino-quinazolines |
| 01/26/2006 | US20060019945 Granzyme b inhibitors |
| 01/26/2006 | US20060019930 Treatment and prevention of tissue damage |
| 01/26/2006 | US20060019897 Anti-angiogenic polypeptides |
| 01/26/2006 | US20060019888 such as viral myocarditis (Coxsackie virus, echovirus, polio virus) or dilated (congestive) cardiomyopathy, by binding ErbB2-ErbB4 receptors; atpase inhibitors |
| 01/26/2006 | US20060019336 Factor VII or VIIa - like molecules |
| 01/26/2006 | US20060019294 Tyrosine kinase substrate (Tks) proteins |
| 01/26/2006 | US20060018894 Administration of enoxoparin sodium to patients 75 years and older with ST-segment elevation myocardial infarction |
| 01/26/2006 | US20060016904 Adjustable non-electric liquid air freshener device |
| 01/26/2006 | DE102004031850A1 Substituirte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituirte tetrahydroisoquinolines as MMP inhibitors, to processes for their preparation and their use as a medicament |
| 01/26/2006 | CA2574381A1 Composition comprising protein material and non-oxidizable fatty acid entities |
| 01/26/2006 | CA2574366A1 Composition comprising plant and/or fish oils and compounds comprising non-oxidizable fatty acid entities |
| 01/26/2006 | CA2574180A1 Substituted benzothiazoles |
| 01/26/2006 | CA2574006A1 Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis |
| 01/26/2006 | CA2573969A1 Oxidative degradation products of atorvastatin calcium |
| 01/26/2006 | CA2572558A1 Methods of treating neurological conditions with hematopoeitic growth factors |
| 01/26/2006 | CA2572047A1 Octahydropyrrolo[2,3,c]pyridine derivatives and pharmaceutical use thereof |
| 01/26/2006 | CA2570800A1 Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines |
| 01/25/2006 | EP1619498A2 Method of screening remedy for heart disease and medicinal composition for treating heart disease |
| 01/25/2006 | EP1619250A1 WSX receptor and ligands |
| 01/25/2006 | EP1619197A1 Substituted Pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-2,4(1H,3H)diones and -4(3H)ones as well as Pyrido[3',2':4,5]furo[3,2-d]-pyrimidin-2,4(1H,3H)diones und -4(3H)ones as inhibitors of TNF-alpha release |
| 01/25/2006 | EP1619196A1 Substituted Pyrido[3',2':4,5]thieno[3,2-d]pyrimidines and Pyrido[3',2':4,5]furo[3,2-d]-pyrimidines for use as inhibitors of PDA-4 and/or TNF-alpha release |
| 01/25/2006 | EP1619193A1 Spiropiperidine compound and medicinal use thereof |
| 01/25/2006 | EP1619192A2 Aryl fused azapolycyclic compounds |
| 01/25/2006 | EP1618885A1 Cosmetic and/or pharmaceutical compositions containing fatty acids and extracts of castanea sativa |
| 01/25/2006 | EP1618879A1 Injectable formulations of taxanes for cad treatment |
| 01/25/2006 | EP1618876A1 Use of sphingolipids for prevention and treatment of atherosclerosis |
| 01/25/2006 | EP1618086A2 Compounds for the treatment of metabolic disorders |
| 01/25/2006 | EP1617856A2 Somatostatin-dopamine chimeric analogs |
| 01/25/2006 | EP1617834A1 Lactate containing pharmaceutical composition and uses thereof |
| 01/25/2006 | EP1617830A2 Esterified fatty acid composition |
| 01/25/2006 | EP1617821A1 Chrono delivery formulations and method of treating atrial fibrillation |
| 01/25/2006 | EP1465620A4 Novel composition of carvedilol |
| 01/25/2006 | EP1372627B1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 01/25/2006 | EP1267901B1 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress |
| 01/25/2006 | EP1235825B1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 01/25/2006 | EP0914158B2 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 01/25/2006 | EP0759781B1 Compositions for treating and preventing atherosclerosis |
| 01/25/2006 | CN1726213A Imidazoquinoline derivatives as adenosine A3 receptor ligands |
| 01/25/2006 | CN1726211A Imidazole deriviatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase |
| 01/25/2006 | CN1726198A Compounds, compositions, and methods |
| 01/25/2006 | CN1726188A Treating syndrome X with substituted tetralins and indanes |
| 01/25/2006 | CN1726062A Liquid pharmaceutical formulations containing 3.7-diazabicyclo[3,3,1]nonane compounds and methods of treatment relating to arrhythmic events |
| 01/25/2006 | CN1726030A Combinations of valsartan with cox-2 inhibitors |
| 01/25/2006 | CN1726023A Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders |
| 01/25/2006 | CN1726022A Pregabalin derivatives for the treatment of fibromyalgia and other disorders and its derivitive |